NK
Nareshbhai Kanjibhai Patel
About Nareshbhai Kanjibhai Patel
Data last updated:
Nareshbhai Kanjibhai Patel is a Director at Zeel Pharma Hub Private Limited (since 2020) and Director at Growzeel Lifescience Private Limited (since 2021). The companies operate in Pharma. The largest current company by reported revenue is Zeel Pharma Hub Private Limited at ₹74.3 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Zeel Pharma Hub Private Limited U51909GJ2020PTC112054 | Director | 10 Jan 2020 | 2020 | ₹74.3 Lakh (FY 2025) | Active |
| Growzeel Lifescience Private Limited U24290GJ2021PTC123560 | Director | 24 Jun 2021 | 2021 | Active |
Board colleagues of Nareshbhai Kanjibhai Patel
| Name | DIN | Company | Designation |
|---|---|---|---|
| Binal Nareshbhai Patel | Zeel Pharma Hub Private Limited | Ceo | |
| Jayeshbhai Kanjibhaio Patel | 08665950 | Zeel Pharma Hub Private Limited , Growzeel Lifescience Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nareshbhai Kanjibhai Patel
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nareshbhai Kanjibhai Patel
Nareshbhai Kanjibhai Patel currently holds 2 directorships: Zeel Pharma Hub Private Limited (Director, since 10 Jan 2020, revenue ₹74.3 Lakh (FY 2025)); Growzeel Lifescience Private Limited (Director, since 24 Jun 2021).
Nareshbhai Kanjibhai Patel was first appointed on 10 Jan 2020 as Director at Zeel Pharma Hub Private Limited. The most recent appointment on record is 24 Jun 2021 at Growzeel Lifescience Private Limited.
The current boards of Nareshbhai Kanjibhai Patel's companies include Binal Nareshbhai Patel (Zeel Pharma Hub Private Limited), Jayeshbhai Kanjibhaio Patel (Zeel Pharma Hub Private Limited).